Nahdi Medical Company (4164.SR) stock analysis

In our weekly check, Nahdi Medical Company is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 15 pass, warnings: 7, red flags: 3.

About Nahdi Medical Company

Nahdi Medical Company is a Healthcare company (Medical - Pharmaceuticals), listed on SAU as 4164.SR.

What our checks show for 4164.SR

Red flags

• The net margin fell by 2.6 points over 5 years, to 7.4%: the company keeps less of each sale as profit.
• The gross margin fell by 3.5 points, to 37.5%: costs are rising faster than prices.
• The stock has fallen as much as 60% from a peak. Would you have held through that?

Warning signs

• Margins expected to shrink
• Earnings per share fell 3.5% a year over the last 3 years.
• Net profit fell 3.5% a year over the last 3 years.
• The net margin is only 7.4%: little room if costs rise.
• The dividend takes 91% of profit: little cushion if profit falls.
• The stock is still below its previous peak.
• Thinly traded (about 123 thousand shares a day): buying and selling can move the price.

Strengths

• Operating cash flow is 1.93x net profit: the profit arrives as real cash.
• Free cash flow is 11.6% of revenue: cash for dividends, buybacks or growth.
• Beta 0.12: the stock usually moves less than the market.
• Return on capital (ROCE) is 20.4%: the business earns well on the money put into it.
• Pay in shares is only 0% of free cash flow.

Similar companies

REC.MI · CORT · KNSA · RADL3.SA

Questions

What grade does Nahdi Medical Company (4164.SR) have?

In our weekly check, Nahdi Medical Company is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 15 pass, warnings: 7, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 4164.SR stock?

This week's biggest flags for Nahdi Medical Company: Margins falling, Gross margin falling, Deep past fall. In total 10 of 25 checks show a warning or a red flag.

What does Nahdi Medical Company do?

Nahdi Medical Company is a Healthcare company (Medical - Pharmaceuticals), listed on SAU as 4164.SR.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-07

Open the full analysis